Zobrazeno 1 - 10
of 184
pro vyhledávání: '"Naoki Hosen"'
Autor:
Moto Yaga, Kana Hasegawa, Shunya Ikeda, Miwa Matsubara, Takashi Hiroshima, Toru Kimura, Yuya Shirai, Wibowo Tansri, Hirofumi Uehara, Mana Tachikawa, Yuzuru Okairi, Masayuki Sone, Hiromi Mori, Yosuke Kogue, Hiroki Akamine, Daisuke Okuzaki, Kotaro Kawagishi, Satoshi Kawanaka, Hiroyuki Yamato, Yukiyasu Takeuchi, Eiji Okura, Ryu Kanzaki, Jiro Okami, Itsuko Nakamichi, Shigeru Nakane, Aki Kobayashi, Takashi Iwazawa, Toshiteru Tokunaga, Hideoki Yokouchi, Yukihiro Yano, Junji Uchida, Masahide Mori, Kiyoshi Komuta, Tetsuro Tachi, Hideki Kuroda, Noriyuki Kijima, Haruhiko Kishima, Michiko Ichii, Shinji Futami, Yujiro Naito, Takayuki Shiroyama, Kotaro Miyake, Shohei Koyama, Haruhiko Hirata, Yoshito Takeda, Soichiro Funaki, Yasushi Shintani, Atsushi Kumanogoh, Naoki Hosen
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Chimeric antigen receptor (CAR) T cells are effective against hematological cancers, but are less effective against solid tumors such as non-small cell lung cancer (NSCLC). One of the reasons is that only a few cell surface targets specific
Externí odkaz:
https://doaj.org/article/dba8be21cd884b8998cbf922a845b421
Autor:
Ritsuko Nakai, Takafumi Yokota, Masahiro Tokunaga, Mikiro Takaishi, Tomomasa Yokomizo, Takao Sudo, Henyun Shi, Yoshiaki Yasumizu, Daisuke Okuzaki, Chikara Kokubu, Sachiyo Tanaka, Katsuyoshi Takaoka, Ayako Yamanishi, Junko Yoshida, Hitomi Watanabe, Gen Kondoh, Kyoji Horie, Naoki Hosen, Shigetoshi Sano, Junji Takeda
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-16 (2024)
Abstract The development of haematopoiesis involves the coordinated action of numerous genes, some of which are implicated in haematological malignancies. However, the biological function of many genes remains elusive and unknown functional genes are
Externí odkaz:
https://doaj.org/article/225283fb9a214aa6b186990211f6ac28
Autor:
Naoki Hosen
Publikováno v:
Inflammation and Regeneration, Vol 44, Iss 1, Pp 1-4 (2024)
Abstract One should identify appropriate cell surface targets to develop new CAR-T cells. Currently, lineage-specific antigens such as CD19 or B cell maturation antigen (BCMA) are being used as targets for CAR-T cells. However, in most cancers, linea
Externí odkaz:
https://doaj.org/article/8e99151d34e14a4bae011ee31ade585d
Autor:
Yutaka Shimazu, Junya Kanda, Satoru Kosugi, Tomoki Ito, Hitomi Kaneko, Kazunori Imada, Yuji Shimura, Shin-ichi Fuchida, Kentaro Fukushima, Hirokazu Tanaka, Satoshi Yoshihara, Kensuke Ohta, Nobuhiko Uoshima, Hideo Yagi, Hirohiko Shibayama, Ryosuke Yamamura, Yasuhiro Tanaka, Hitoji Uchiyama, Yoshiyuki Onda, Yoko Adachi, Hitoshi Hanamoto, Ryoichi Takahashi, Mitsuhiro Matsuda, Takashi Miyoshi, Teruhito Takakuwa, Masayuki Hino, Naoki Hosen, Shosaku Nomura, Chihiro Shimazaki, Itaru Matsumura, Akifumi Takaori-Kondo, Junya Kuroda
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Novel therapeutic drugs have dramatically improved the overall survival of patients with multiple myeloma. We sought to identify the characteristics of patients likely to exhibit a durable response to one such drug, elotuzumab, by analyzing
Externí odkaz:
https://doaj.org/article/f9f360c7a7b8496ea74ce32ada6c5c4d
Autor:
Ritsuko Nakai, Takafumi Yokota, Masahiro Tokunaga, Mikiro Takaishi, Takao Sudo, Henyun Shi, Yoshiaki Yasumizu, Daisuke Okuzaki, Chikara Kokubu, Sachiyo Tanaka, Katsuyoshi Takaoka, Ayako Yamanishi, Junko Yoshida, Hitomi Watanabe, Gen Kondoh, Kyoji Horie, Naoki Hosen, Shigetoshi Sano, Junji Takeda
Publikováno v:
HemaSphere, Vol 7, p e1226943 (2023)
Externí odkaz:
https://doaj.org/article/c8c4004ed2c8497086ff8791e66a1b8a
Autor:
Akihisa Hino, Kentaro Fukushima, Shinsuke Kusakabe, Tomoaki Ueda, Takao Sudo, Jiro Fujita, Daisuke Motooka, Takafumi Yokota, Hirohiko Shibayama, Shota Nakamura, Naoki Hosen
Publikováno v:
HemaSphere, Vol 7, p e245098c (2023)
Externí odkaz:
https://doaj.org/article/8b337b5172334435a0f434c2392d39f6
Autor:
Kentaro Fukushima, Hayami Kudo, Kentaro Oka, Atsushi Hayashi, Makoto Onizuka, Shinsuke Kusakabe, Akihisa Hino, Motomichi Takahashi, Kiyoshi Takeda, Masaki Mori, Kiyoshi Ando, Naoki Hosen
Publikováno v:
HemaSphere, Vol 7, p e200988b (2023)
Externí odkaz:
https://doaj.org/article/dceaf68530494f41b1d4c497a3776c92
Autor:
Tsunaki Higa, Yasutaka Okita, Akinobu Matsumoto, Shogo Nakayama, Takeru Oka, Osamu Sugahara, Daisuke Koga, Shoichiro Takeishi, Hirokazu Nakatsumi, Naoki Hosen, Sylvie Robine, Makoto M. Taketo, Toshiro Sato, Keiichi I. Nakayama
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-17 (2022)
Rapid turnover and regeneration of intestinal epithelium requires distinct intestinal stem cell (ISC) populations. Here the authors show p57 marks quiescent ISCs, and that differentiated cells revert to stem cell state after injury, through dynamic r
Externí odkaz:
https://doaj.org/article/016b3ef4cf6d4e8f94825f680194ae25
Autor:
Aya Nakaya, Hirohiko Shibayama, Nobuhiko Uoshima, Ryosuke Yamamura, Satoshi Yoshioka, Kazunori Imada, Yuji Shimura, Masaaki Hotta, Toshimitsu Matsui, Satoru Kosugi, Hitoshi Hanamoto, Hitoji Uchiyama, Satoshi Yoshihara, Shin-ichi Fuchida, Yoshiyuki Onda, Yasuhiro Tanaka, Kensuke Ohta, Mitsuhiro Matsuda, Junya Kanda, Adachi Yoko, Miki Kiyota, Eri Kawata, Ryoichi Takahashi, Kentaro Fukushima, Hirokazu Tanaka, Hideo Yagi, Teruhito Takakuwa, Naoki Hosen, Tomoki Ito, Chihiro Shimazaki, Akifumi Takaori-Kondo, Junya Kuroda, Itaru Matsumura, Masayuki Hino
Publikováno v:
Leukemia Research Reports, Vol 20, Iss , Pp 100395- (2023)
To evaluate the specific prognostic value of CAs, we conducted an analysis of 923 symptomatic multiple myeloma patients. Among this cohort, 480 patients had complete data set of high-risk CAs by interphase fluorescent in situ hybridization at diagnos
Externí odkaz:
https://doaj.org/article/82b016d7b6d64623a8db970348a6c492
Autor:
Yutaka Shimazu, Junya Kanda, Hitomi Kaneko, Kazunori Imada, Ryosuke Yamamura, Satoru Kosugi, Yuji Shimura, Tomoki Ito, Shin-ichi Fuchida, Hitoji Uchiyama, Kentaro Fukushima, Satoshi Yoshihara, Hitoshi Hanamoto, Hirokazu Tanaka, Nobuhiko Uoshima, Kensuke Ohta, Hideo Yagi, Hirohiko Shibayama, Yoshiyuki Onda, Yasuhiro Tanaka, Yoko Adachi, Mitsuhiro Matsuda, Masato Iida, Takashi Miyoshi, Toshimitsu Matsui, Ryoichi Takahashi, Teruhito Takakuwa, Masayuki Hino, Naoki Hosen, Shosaku Nomura, Chihiro Shimazaki, Itaru Matsumura, Akifumi Takaori-Kondo, Junya Kuroda
Publikováno v:
Therapeutic Advances in Hematology, Vol 13 (2022)
Background: Daratumumab is one of the most widely used treatments for relapsed/refractory multiple myeloma (MM) patients. However, not all patients achieve a lasting therapeutic response with daratumumab. Objectives: We hypothesized that a durable re
Externí odkaz:
https://doaj.org/article/de0e47159d65497ba083e4d809b5a35a